<bill session="119" type="h" number="2343" updated="2025-11-13T09:05:40Z">
  <state datetime="2025-03-25">REFERRED</state>
  <status>
    <introduced datetime="2025-03-25"/>
  </status>
  <introduced datetime="2025-03-25"/>
  <titles>
    <title type="display">John W. Walsh Alpha-1 Home Infusion Act of 2025</title>
    <title type="short" as="introduced">John W. Walsh Alpha-1 Home Infusion Act of 2025</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to provide for coverage and payment of Alpha-1 Antitrypsin Deficiency Disorder treatment under part B of such title, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="S000168"/>
  <cosponsors>
    <cosponsor bioguide_id="B001298" joined="2025-11-07"/>
    <cosponsor bioguide_id="B001326" joined="2025-09-19"/>
    <cosponsor bioguide_id="C001125" joined="2025-06-30"/>
    <cosponsor bioguide_id="C001136" joined="2025-09-19"/>
    <cosponsor bioguide_id="C001119" joined="2025-06-10"/>
    <cosponsor bioguide_id="F000474" joined="2025-11-04"/>
    <cosponsor bioguide_id="G000583" joined="2025-08-08"/>
    <cosponsor bioguide_id="J000288" joined="2025-03-25"/>
    <cosponsor bioguide_id="K000398" joined="2025-07-29"/>
    <cosponsor bioguide_id="K000375" joined="2025-06-30"/>
    <cosponsor bioguide_id="K000402" joined="2025-05-29"/>
    <cosponsor bioguide_id="K000397" joined="2025-03-25"/>
    <cosponsor bioguide_id="L000600" joined="2025-06-05"/>
    <cosponsor bioguide_id="L000557" joined="2025-09-09"/>
    <cosponsor bioguide_id="L000606" joined="2025-09-19"/>
    <cosponsor bioguide_id="L000599" joined="2025-06-05"/>
    <cosponsor bioguide_id="L000562" joined="2025-11-12"/>
    <cosponsor bioguide_id="M001230" joined="2025-10-24"/>
    <cosponsor bioguide_id="M000317" joined="2025-08-01"/>
    <cosponsor bioguide_id="M001228" joined="2025-10-17"/>
    <cosponsor bioguide_id="M001163" joined="2025-09-04"/>
    <cosponsor bioguide_id="M001238" joined="2025-10-24"/>
    <cosponsor bioguide_id="M001229" joined="2025-08-08"/>
    <cosponsor bioguide_id="N000191" joined="2025-07-29"/>
    <cosponsor bioguide_id="N000147" joined="2025-03-25"/>
    <cosponsor bioguide_id="O000086" joined="2025-03-25"/>
    <cosponsor bioguide_id="P000613" joined="2025-07-29"/>
    <cosponsor bioguide_id="P000597" joined="2025-03-25"/>
    <cosponsor bioguide_id="R000305" joined="2025-10-08"/>
    <cosponsor bioguide_id="R000603" joined="2025-03-25"/>
    <cosponsor bioguide_id="R000599" joined="2025-06-05"/>
    <cosponsor bioguide_id="R000609" joined="2025-09-19"/>
    <cosponsor bioguide_id="S001207" joined="2025-06-05"/>
    <cosponsor bioguide_id="S001172" joined="2025-10-21"/>
    <cosponsor bioguide_id="S000522" joined="2025-03-25"/>
    <cosponsor bioguide_id="T000469" joined="2025-03-25"/>
    <cosponsor bioguide_id="V000129" joined="2025-10-08"/>
    <cosponsor bioguide_id="V000133" joined="2025-10-14"/>
    <cosponsor bioguide_id="V000138" joined="2025-10-03"/>
    <cosponsor bioguide_id="W000822" joined="2025-07-29"/>
    <cosponsor bioguide_id="W000814" joined="2025-08-01"/>
  </cosponsors>
  <actions>
    <action datetime="2025-03-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2025-03-25" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2025-03-25">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referred To"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referred To"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2025-04-18T17:27:26Z" status="Introduced in House">John W. Walsh Alpha-1 Home Infusion Act of 2025

This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.</summary>
</bill>
